Insider Trading & Ownership - Deignan Charles A.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Deignan Charles A.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-19
Sale
2024-01-19
6:25 pm
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
12,900$1.28$16,512584,662
(Direct)
View
2023-01-19
Sale
2023-01-20
4:29 pm
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
14,030$1.5$21,045363,472
(Direct)
View
2022-01-19
Sale
2022-01-20
7:07 pm
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
8,833$2.09$18,461482,616
(Direct)
View
2021-09-21
Sale
2021-09-23
5:12 pm
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
2,800$6.41$17,948316,449
(Direct)
View
2021-06-21
Sale
2021-06-23
5:42 pm
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
2,938$4.37$12,839319,249
(Direct)
View
2020-06-01
Sale
2020-06-03
4:43 pm
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
14,992$1.88$28,185220,827
(Direct)
View
2019-11-12
Purchase
2019-11-13
08:38 am
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
7,500$1.14$8,550203,856
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-18
Option Award
2024-01-19
6:25 pm
N/A
2034-01-18
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
200,000$0584,662
(Direct)
View
2023-09-18
Option Award
2023-09-20
4:30 pm
N/A
2033-09-18
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
100,000$0100,000
(Direct)
View
2023-09-13
Exercise
2023-09-13
6:55 pm
N/A
N/A
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
34,090$0.4397,562
(Direct)
View
2023-09-13
Exercise
2023-09-13
6:55 pm
N/A
2023-11-24
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
34,090$0397,562
(Direct)
View
2023-01-04
Option Award
2023-01-06
4:28 pm
N/A
2033-01-04
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
187,500$0187,500
(Direct)
View
2022-12-20
Exercise
2022-12-20
4:38 pm
N/A
N/A
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
23,636$0.4377,502
(Direct)
View
2022-12-20
Exercise
2022-12-20
4:38 pm
N/A
2023-02-28
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
23,636$0377,502
(Direct)
View
2022-01-18
Option Award(A)
2022-01-28
4:51 pm
N/A
2032-01-18
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
185,000$0501,449
(Direct)
View
2022-01-18
Option Award
2022-01-20
7:07 pm
N/A
2032-01-18
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
175,000$0482,616
(Direct)
View
2021-01-18
Option Award
2021-01-20
6:18 pm
N/A
2031-01-18
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
292,000$0517,827
(Direct)
View
2020-01-08
Option Award
2020-01-10
6:02 pm
N/A
2030-01-08
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
100,000$0303,856
(Direct)
View
2019-09-18
Option Award
2019-09-20
4:55 pm
N/A
N/A
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
70,000$0196,356
(Direct)
View
2019-05-31
Option Award
2019-06-04
5:11 pm
N/A
N/A
Clearside Biomedical Inc.CLSDDeignan Charles A.
Chief Financial Officer
50,000$0126,356
(Direct)
View
(A) Indicate amendment filing.